Literature DB >> 28241335

Using Design Thinking to Differentiate Useful From Misleading Evidence in Observational Research.

Steven N Goodman1, Sebastian Schneeweiss2, Michael Baiocchi3.   

Abstract

Mesh：

Year:  2017        PMID： 28241335     DOI： 10.1001/jama.2016.19970

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

Review 1.  Personalized evidence based medicine: predictive approaches to heterogeneous treatment effects.

Authors:  David M Kent; Ewout Steyerberg; David van Klaveren
Journal:  BMJ       Date:  2018-12-10

2.  Epidemiology at a time for unity.

Authors:  Bryan Lau; Priya Duggal; Stephan Ehrhardt
Journal:  Int J Epidemiol       Date:  2018-10-01       Impact factor: 7.196

3.  stratamatch: Prognostic Score Stratification Using a Pilot Design.

Authors:  Rachael C Aikens; Joseph Rigdon; Justin Lee; Michael Baiocchi; Andrew B Goldstone; Peter Chiu; Y Joseph Woo; Jonathan H Chen
Journal:  R J       Date:  2021-06       Impact factor: 1.673

4.  Use of Health Care Databases to Support Supplemental Indications of Approved Medications.

Authors:  Michael Fralick; Aaron S Kesselheim; Jerry Avorn; Sebastian Schneeweiss
Journal:  JAMA Intern Med       Date:  2018-01-01       Impact factor: 21.873

5.  How do we determine the impact of e-cigarettes on cigarette smoking cessation or reduction? Review and recommendations for answering the research question with scientific rigor.

Authors:  Andrea C Villanti; Shari P Feirman; Raymond S Niaura; Jennifer L Pearson; Allison M Glasser; Lauren K Collins; David B Abrams
Journal:  Addiction       Date:  2017-10-03       Impact factor: 6.526

6.  Data Rich, Information Poor: Can We Use Electronic Health Records to Create a Learning Healthcare System for Pharmaceuticals?

Authors:  Hans-Georg Eichler; Brigitte Bloechl-Daum; Karl Broich; Paul Alexander Kyrle; Jillian Oderkirk; Guido Rasi; Rui Santos Ivo; Ad Schuurman; Thomas Senderovitz; Luke Slawomirski; Martin Wenzl; Valerie Paris
Journal:  Clin Pharmacol Ther       Date:  2018-10-14       Impact factor: 6.875

7.  Comparative safety and effectiveness of dabigatran vs. rivaroxaban and apixaban in patients with non-valvular atrial fibrillation: a retrospective study from a large healthcare system.

Authors:  Todd C Villines; Azhar Ahmad; Michaela Petrini; Wenbo Tang; Amber Evans; Toni Rush; David Thompson; Kelly Oh; Eric Schwartzman
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2019-04-01

8.  Desmopressin and the risk of hyponatremia: A population-based cohort study.

Authors:  Michael Fralick; Sebastian Schneeweiss; Christopher J D Wallis; Emily H Jung; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2019-10-21       Impact factor: 11.069

Review 9.  The ACTTION Guide to Clinical Trials of Pain Treatments, part II: mitigating bias, maximizing value.

Authors:  Robert H Dworkin; Robert D Kerns; Michael P McDermott; Dennis C Turk; Christin Veasley
Journal:  Pain Rep       Date:  2021-01-21

10.  Use of real-world evidence in postmarketing medicines regulation in the European Union: a systematic assessment of European Medicines Agency referrals 2013-2017.

Authors:  Jeremy Philip Brown; Kevin Wing; Stephen J Evans; Krishnan Bhaskaran; Liam Smeeth; Ian J Douglas
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.